On the first use of 1 oz (28.5 g) tubes remove the cap, then the protective seal and close with the cap after use. Ensure that the affected superficial area is clean and dry. Apply a very thin layer of Derpixa directly to the affected area and allow the gel to dry. When applied correctly to exposed areas, Derpixa should be dry in 5–6 minutes. If it takes longer to dry you have probably applied too much. Gently rem...
Rx Only
For topical use only
Federal Law restricts this device to sale by or on the order of a licensed healthcare practitioner.
Derpixa is an occlusive, non-resorbable, self-drying and transparent gel.
When used as directed Derpixa dries to form a protective layer that is gas permeable and waterproof which hydrates and protects compromised skin areas and superficial wounds from chemical and microbial invasion.
Derpixa helps to promote a moist healing environment.
This moist wound healing environment promotes faster re-epithelialization1and reduces the skin's acute inflammatory response.
Derpixa is suitable for large surface areas and contoured skin like head, face, hand and foot, as well as joints and hairy areas without the need for shaving.
1 Losi P et al. J Mater Sci Mater Med.2012;23(9):2235–43
Derpixa is intended to be used under the direction of healthcare practitioners in the management of cutaneous reactions.
Derpixa is indicated for use on all types of wounds, toxic and compromised skin including:
Derpixa is indicated for the relief of dry, itching, flaking, peeling and irritated skin, as well as the symptomatic relief of pain, redness and heat sensation.
Derpixa may be directly applied to dry skin, open wounds and compromised or desquamating skin surfaces, including cutaneous rashes.
Derpixa gel is bacteriostatic and inert.
It contains no alcohols, parabens or fragrances.
Derpixa can be used with or without a secondary protective dressing.
Derpixa is suitable for children and people with sensitive skin.
Derpixa is intended for single patient use.
| On the first use of 1 oz (28.5 g) tubes remove the cap, then the protective seal and close with the cap after use. |
Ensure that the affected superficial area is clean and dry.
Apply a very thin layer of Derpixa directly to the affected area and allow the gel to dry.
When applied correctly to exposed areas, Derpixa should be dry in 5–6 minutes.
If it takes longer to dry you have probably applied too much.
Gently remove the excess with a clean tissue or gauze and allow the drying process to continue.
Once dry, Derpixa may be covered by sunscreen, cosmetics and clothing.
Derpixa should be applied at least twice daily to affected areas, as needed or as advised by your physician.
For best results Derpixa should be maintained in continuous contact with the skin (24 hours a day/7 days a week).
How much Derpixa do I need?
Derpixa gel is an advanced formulation that requires substantially less product per application than typical creams or gels.
Derpixa 1 oz (28.5 g) is enough to treat an area of 6 × 12 inch (15 × 30 cm) twice per day for 30 days.
Do not administer to patients with known hypersensitivity to the ingredients of this product.
Ingredients: Dimethylpolysiloxane, dihydroxysiloxane and alkylmethylsiloxane.
Derpixa 1 oz (28.5 g) tube
Product identification code: 79043-150-28
| Consult instructions for use |
| Use by date |
| Batch code |
| Sterilized using irradiation |
| Do not use if the tube is damaged |
| Upper limit of temperature |
Stratpharma AG
Aeschenvorstadt 57
CH-4051 Basel
Switzerland
Distributed by
Allegis Pharmaceuticals
Canton, MS 39046, USA
Date of preparation of this
information: 10/2020
Stratpharma
Switzerland
scite
PHARMA
Questions:
1-866-633-9033
CE
DP000USENPI01-1020
79043-150-28
Rx Only
For topical use only
ADVANCED FORMULATION
Derpixa
for cutaneous reactions
gel
1 oz
28.5 g
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 79043-150-28 | Derpixa | 28.5 g in 1 TUBE | 28.5 | 2 | ||
| 79043-150-28 | Derpixa | 1 in 1 BOX | 1 | 2 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 79043-150-28 | GM - Gram | 79043-150 | 69ca937f-3ff3-4c74-9934-55b0512e2025 | 1 | 2021-02-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 79043-150 | 79043-150-28 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMETHICONE | 92RU3N3Y1O | IACT |
| DIMETHICONOL (2000 CST) | T74O12AN6Y | IACT |
| DIDECYLDIMONIUM CHLORIDE | JXN40O9Y9B | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.
